When a clinical trial is completed, regardless of the outcome, the results need to be shared. From a regulatory perspective, they have to be shared. On the other hand, from the perspective of disseminating information throughout the scientific community, researchers...
Approximately 90 percent of global pharmaceutical companies are using, or have plans to use real world data in the near future, according to a 2018 benchmarking survey from Deloitte. This coincides with an increased focus on the use of real world evidence from the...
In the early 2000s, I sat in an undergraduate microbiology lab and caught the bug. It was not a laboratory-acquired infection, but inspiration from a world only seen under the microscope. The order and the vast unknown was intriguing, leading me to expand my...
The pharmaceutical industry has eclipsed 4.4 million employees globally. With worldwide sales planned to increase from $860 billion in 2019 to more than $1.06 trillion by 2022, project resourcing will be even more critical than it is today. The continued expansion of...
According to Mentoring.org, young adults who are mentored are 130 percent more likely to hold leadership positions in the future. Strong mentors assist is building strong junior-level colleagues – especially in the pharmaceutical and biotech industries. As with all...
For this edition of Expert Insights, we talk with Doreen van Huyssteen, Manager of Data Management at MMS – based in Bloemfontein, South Africa. What is the difference between CDISC and CDASH, and why should these standards be followed? The Clinical Data Interchange...
Medical writers are the people that tell the story of new drugs coming to market. It’s a very important job, and one that needs to be performed to exact specifications. While attending the invitation-only Medical Writing Executives Forum: Preparing for the Future of...
Executives come and go, but strong leaders like Kelly J. Hill, help shape an organization and its future. As Executive Director, Global Business Operations & Strategy at MMS, Kelly discusses how thoughtful planning, strong values, and a company focus on data...
Plain language summaries, commonly known as lay summaries, have become increasingly important for pharmaceutical companies in recent years. However, there are many sponsors that have yet to start their pilot programs for these documents. To answer some commonly-asked...